Delivery Order SPE2DB20D9329-SPE2DB25FZK34
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,603.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $4,166.24, was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025. The contract utilizes no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, was awarded without set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK34Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a continuation of DMS Pharmaceutical Group's established relationship with DLA as a critical supplier within the federal pharmaceutical supply chain. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business entity. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. The IDC authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group's role as a primary pharmaceutical distributor to Department of Defense healthcare sites positions the company as an essential provider of both routine medications and specialized pharmaceutical products, including contraceptive devices such as the Mirena system ordered under this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 6/6/25 |